bibliographicCitation |
Lee J, Suh C, Kang HJ, Ryoo B-, Huh J, Ko YH, Eom H-, Kim K, Park K, Kim WS. Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma. Annals of Oncology. 2008 Dec;19(12):2079–83. doi: 10.1093/annonc/mdn431. |